Afuco™ Anti-Human LAMTOR3 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-LAMTOR3 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-human Mp1 antibodies found to exhibit a high agonistic activity. This shows that the activity of an antibody can be enhanced by making the antibody into a single-chain polypeptide that comprises two or more heavy chain variable regions and two or more light chain variable regions linked via linkers. It can be used for treatment of breast cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-464CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | LAMTOR3 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C |